首页> 外国专利> METHOD OF TREATING BREAST CANCER USING NANOPARTICLES COMPRISING TAXANE BASED ON HORMONE RECEPTOR STATUS

METHOD OF TREATING BREAST CANCER USING NANOPARTICLES COMPRISING TAXANE BASED ON HORMONE RECEPTOR STATUS

机译:基于激素受体状态的含紫杉烷的纳米微粒治疗乳腺癌的方法

摘要

PROBLEM TO BE SOLVED: To provide a method of treating breast cancer using nanoparticles comprising taxane based on a hormone receptor status.SOLUTION: The present invention relates to a method and a kit for treatment of breast cancer based on the hormone receptor status of a progesterone receptor and an estrogen receptor, and the method and the kit comprise taxane alone, in combination with at least one other and other multiple therapeutic agents, as well as other treatment forms useful for treatment of breast cancer. In particular, the invention relates to use of nanoparticles comprising paclitaxel and albumin (for example Abraxane(R)) either alone or in combination with other chemotherapeutic agents or radiation, which can be used for treatment of breast cancer not expressing estrogen receptors and/or progesterone receptors.
机译:解决的问题:提供一种基于荷尔蒙受体状态使用包含紫杉烷的纳米粒子治疗乳腺癌的方法。解决方案:本发明涉及一种基于孕激素的荷尔蒙状态治疗乳腺癌的方法和试剂盒。受体和雌激素受体,以及该方法和试剂盒仅包含紫杉烷,与至少一种其他和其他多种治疗剂结合,以及可用于治疗乳腺癌的其他治疗形式。特别地,本发明涉及单独或与其他化学治疗剂或放射线组合使用的包含紫杉醇和白蛋白的纳米颗粒(例如Abraxane)的用途,其可用于治疗不表达雌激素受体和/或的乳腺癌。孕激素受体。

著录项

  • 公开/公告号JP2014080443A

    专利类型

  • 公开/公告日2014-05-08

    原文格式PDF

  • 申请/专利权人 ABRAXIS BIOSCIENCE LLC;

    申请/专利号JP20140023616

  • 发明设计人 NEIL P DESAI;PATRICK SOON-SHIONG;

    申请日2014-02-10

  • 分类号A61K9/16;A61K31/337;A61K47/42;A61K45;A61K31/513;A61K31/704;A61K31/675;A61P43;A61P35;

  • 国家 JP

  • 入库时间 2022-08-21 16:15:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号